Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer

Prolactin (PRL) has been reported to inhibit apoptosis in various cell types and to serve as a cofactor in the upregulation of CD25 on T cells during activation. We investigated a possible relation between prolactin receptor (PRL-R) or IL-2 receptor alpha (IL-2Rα, CD25) expression on circulating T l...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauernhofer, T, Kuss, I, Friebe-Hoffmann, U, Baum, A S, Dworacki, G, Vonderhaar, B K, Whiteside, T L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747567/
https://www.ncbi.nlm.nih.gov/pubmed/12698200
http://dx.doi.org/10.1038/sj.bjc.6600860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747567/
https://www.ncbi.nlm.nih.gov/pubmed/12698200
http://dx.doi.org/10.1038/sj.bjc.6600860

Ejemplares similares